STRS Ohio’s Allena Pharmaceuticals ALNA Stock Holding History

STRS Ohio’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,500	Closed	-$10K	–	2246
2019 Q1	$10K	Hold	1,500	–	–	﹤0.01%	2011
2018 Q4	$8K	Hold	1,500	–	–	﹤0.01%	2042
2018 Q3	$16K	Hold	1,500	–	–	﹤0.01%	2056
2018 Q2	$19K	Hold	1,500	–	–	﹤0.01%	2061
2018 Q1	$16K	Hold	1,500	–	–	﹤0.01%	1827
2017 Q4	$15K	Buy	+1,500	New	+$18.5K	﹤0.01%	1834

Other funds holding ALNA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

STRS Ohio's ALNA Position: Q2 2019 in Review

STRS Ohio sold out of Allena Pharmaceuticals (ALNA) in Q2 2019, closing a stake of 1,500 shares — an estimated $10K sold.

STRS Ohio first reported a position in ALNA in Q4 2017 and held it in 6 quarters. The position peaked at $19K in Q2 2018. 46 funds tracked by Wall St. Rank hold ALNA as of Q2 2019.

STRS Ohio reported no remaining Allena Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
STRS Ohio sold 1,500 Allena Pharmaceuticals shares in Q2 2019, an estimated $10K.
STRS Ohio first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 6 quarters.
STRS Ohio's Allena Pharmaceuticals position peaked at $19K in Q2 2018.
46 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2019.

Based on STRS Ohio's 13F filing for Q2 2019, filed 25 Jul 2019.